| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |